Patrick Menasco > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
901 NEW YORK AVENUE, NW
WASHINGTON DC 20001
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Patrick Menasco
Position
PartnerÂ
Career
Patrick Menasco is a partner in and co-chair of the firm’s ERISA & Executive Compensation practice. With more than 27 years of public and private sector experience, Mr. Menasco enjoys longstanding connections with regulators and a broad proficiency in Title I and Title IV of ERISA and the regulation of IRAs under the Internal Revenue Code. His clients include national and international private equity and real estate fund sponsors, financial institutions, technology startups and crypto/digital asset investors, traders and service providers. His practice focuses on ERISA regulatory exceptions for private investment funds, ERISA and IRA regulatory issues in crypto/digital asset markets, the operation and management of collective trusts, stable value funds and other ERISA-regulated funds, Title IV merger and acquisition issues, ERISA-regulated capital market transactions, U.S. Department of Labor investigations, and ERISA litigation strategies.
Education
JD, Tulane University Law School (magna cum laude; Order of the Coif) 1994 / BA, Tulane University 1991
Lawyer Rankings
United States > Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
Goodwin has strong expertise in ERISA and executive compensation, offering experience to advising clients on the full spectrum of compensation and benefits matters. Co-chaired by Patrick Menasco in Washington DC, and James Mattus in Boston, the team is known for its deep expertise in M&A, IPOs, private equity, and fiduciary issues under ERISA. The firm is a go-to advisor for financial institutions, investment funds, and emerging growth companies, offering strategic counsel on equity arrangements, golden parachutes, and retirement plan structures.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation